ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Imaging"

  • Abstract Number: 0159 • ACR Convergence 2021

    Structural Damage in Axial Spondyloarthritis: Is There a Preferred Way to Assess Progression over Time?

    Xenofon Baraliakos1, Valeria Rios Rodriguez2, Murat Torgutalp2, Anil Dilbaryan2, Hildrun Haibel3, Maryna Verba4, Joachim Sieper3, Jürgen Braun1, Martin Rudwaleit5 and Denis Poddubnyy6, 1Rheumazentrum Ruhrgebiet Herne, Ruhr-Universität Bochum, Herne, Germany, 2Charité University Medicine Berlin, Berlin, Germany, 3Department of Gastroenterology, Infectiology and Rheumatology (including Nutrition Medicine), Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany, 4Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin Department of Gastroenterology, Infectiology and Rheumatology (including Nutrition Medicine), Berlin, Germany, 5University of Bielefeld, Klinikum Bielefeld, Bielefeld, Germany, 6Department of Rheumatology, Charité – Universitätsmedizin, Berlin, Germany

    Background/Purpose: The aim of this study is to investigate the performance of the modified Stokes Ankylosing Spondylitis Scoring System (mSASSS) in assessing spinal radiographic damage…
  • Abstract Number: 0391 • ACR Convergence 2021

    High Frequency Ultrasound Imaging of Skin Thickness in Patients with Early Diffuse Cutaneous Systemic Sclerosis: An Objective Outcome Measure to Track Change over Time

    Elizabeth Marjanovic1, Calvin Heal1, Tonia Moore1, Joanne Manning2, Sarah Wilkinson1, Graham Dinsdale2, Mark Dickinson1, Jack Wilkinson1, Ariane Herrick3 and Andrea Murray1, 1University of Manchester, Manchester, United Kingdom, 2Salford Royal NHS Foundation Trust, Manchester, United Kingdom, 3University of Manchester, Salford, United Kingdom

    Background/Purpose: There are currently no validated objective measures of systemic sclerosis (SSc)-related skin thickening and this hampers clinical trials of potential new treatments. The modified…
  • Abstract Number: 1210 • ACR Convergence 2021

    Frequency of Anterior Atlanto-Axial Subluxation in Patients with Rheumatoid Arthritis

    Joan Manuel Dapeña1, Eliana Serrano1, Silvana Perez1, Juan Manuel Bande1, Belen Barrios1, María Alejandra Medina1, Diana Klajn1, Jose Caracciolo1, Mariana Benegas2, Analía Dellepiane3, Julieta Silvana Morbiducci4, Maria Cecilia Castro4, Anastasia Secco4, Julia Sosa5, María Paula Kohan6, María Noelia Bersano7, Yamila Chichotky8, José Luis Velasco Zamora9, Víctor Leonardo Yohena10, Laura Rocca10, analia alvarez11, Karin Ingrid Kirmayr12, Galo Saltos Farinango13, Oscar Rillo14, María de los Ángeles Correa15, Analía Verónica Bohr16, Adriana Pérez Dávila17, Nicolas Perez18 and Silvia Papasidero1, 1Hospital General de Agudos Dr. Enrique Tornú, Buenos Aires, Argentina, 2Sanatorio Dr. Julio Méndez, Buenos Aires, Argentina, 3Centro de Especialidades Médicas Caseros, Casilda, Santa Fé, Casilda, Santa Fé, Argentina, 4Hospital General de Agudos Bernardino Rivadavia, Buenos Aires, Argentina, 5Hospital Municipal Dr. Raúl F. Larcade, San Miguel, Buenos Aires, Argentina, 6Hospital Municipal Dr. Raúl F. Larcade, San Miguel, Pilar, Argentina, 7Hospital Provincial de Rosario, Santa Fé, Argentina, 8Reumatología al Sur, Berazategui, Buenos Aires, Argentina, 9Reumatología al Sur, Berazategui, Berazategui, Argentina, 10Hospital General de Agudos Dr. José Penna, Buenos Aires, Buenos Aires, Argentina, 11Hospital General de Agudos Dr. José Penna, Buenos Aires, Argentina, 12Sanatorio San Carlos, Bariloche, Argentina, 13Hospital General de Agudos Dr. Ignacio Pirovano, Buenos Aires, Argentina, 14Hospital I. Pirovano, Buenos Aires, Argentina, 15Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, 16Hospital de Rehabilitación M. Rocca, Ciudad autónoma de Buenos Aires, Argentina, 17Hospital de Rehabilitación M. Rocca, Buenos Aires, Argentina, 18Instituto de Investigaciones Médicas Alfredo Lanari, Buenos Aires, Argentina

    Background/Purpose: According to some series, cervical spine is the second most affected region in Rheumatoid arthritis (RA). Cervical involvement was reported in 80% of RA…
  • Abstract Number: 0161 • ACR Convergence 2021

    Does 18F-FDG-PET/MRI Add Metabolic Information to Anatomic Image in Childhood-onset Takayasu’s Arteritis Patients? A Multicenter Case Series

    Gleice Clemente1, Alexandre Souza2, Hilton Leão Filho3, Fernando Coelho3, Carlos Buchpiguel4, Marcos Lima4, Daniela Petry Pioto5, Melissa Fraga1, Ana Paula Sakamoto6, Camila Carneiro4, Rosa Pereira7, Nadia Aikawa7, Clovis Artur Silva7, Lucia Campos8, Camilla Astley9, Bruno Gualano10 and Maria Terreri11, 1Universidade Federal de São Paulo, São Paulo, Brazil, 2UNIFESP-EPM, São Paulo, Brazil, 3Universidade de Sao Paulo/Radiology Institute, São Paulo, Brazil, 4Universidade de São Paulo/Department of Radiology and Oncology, São Paulo, Brazil, 5Pediatric Rheumatology Unit, Universidade Federal de São Paulo, São Paulo, SP, Brazil, 6Federal University of So Paulo (UNIFESP), São Paulo, Brazil, 7Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, 8children's institute, Sao Paulo, Brazil, 9University of Sao Paulo, Sao Paulo, Brazil, 10Universidade de Sao Paulo/Rheumatology Division, São Paulo, Brazil, 11UNIFESP, São Paulo, Brazil

    Background/Purpose: The disease activity assessment in c-TA is a challenge in clinical practice, especially in patients who are under immunosuppression. Our aim was to perform…
  • Abstract Number: 0394 • ACR Convergence 2021

    Hyperspectral Imaging in Systemic Sclerosis-Raynaud Phenomenon

    Akash Gupta1, Shannon Teaw2, Alyssa Williams2, F. Perry Wilson3, Brandon Sumpio4, Bauer Sumpio4 and Monique Hinchcliff5, 1Department of Medicine, Yale University School of Medicine, New Haven, CT, 2Section of Rheumatology, Allergy & Immunology, Department of Medicine, Yale School of Medicine, New Haven, CT, 3Section of Nephrology, Department of Medicine, Yale School of Medicine, New Haven, CT; Department of Medicine Clinical and Translational Research Accelerator Yale School of Medicine, New Haven, CT, 4Division of Vascular Surgery, Department of Surgery, Yale School of Medicine, New Haven, CT, 5Yale School of Medicine, Westport, CT

    Background/Purpose: Raynaud phenomenon (RP), a microcirculatory, vasospastic disorder, may be primary or secondary to an autoimmune disease [e.g., an early indicator of systemic sclerosis (SSc)].…
  • Abstract Number: 1306 • ACR Convergence 2021

    Clinical and Imaging Characteristics of Spondyloarthritis Among Crohn’s Disease Patients

    Laarni Quimson1, Nisa Oren2, Catherine Burns3 and Reem Jan2, 1University of Chicago, Oak Park, IL, 2University of Chicago, Chicago, IL, 3Indiana University, Indianapolis, IN

    Background/Purpose: Inflammatory bowel disease (IBD) affects up to 1.3% of the population and is associated with musculoskeletal manifestations including spondyloarthritis (SpA). Axial SpA (axSpA) is…
  • Abstract Number: 0162 • ACR Convergence 2021

    Cardiac Magnetic Resonance Imaging for Guiding Decision-making on Treatment Duration: Data from RHAPSODY, a Phase 3 Clinical Trial of Rilonacept in Recurrent Pericarditis

    Paul Cremer1, David Lin2, Alistair Wheeler3, Antonio Abbate4, Antonio Brucato5, Fang Fang6, Antonella Insalaco7, Martin LeWinter8, Basil S. Lewis9, Sushil A. Luis10, Stephen J. Nicholls11, John Petersen12, Allan Klein1, Massimo Imazio13 and John F Paolini6, 1Department of Cardiovascular Imaging, Center for the Diagnosis and Treatment of Pericardial Diseases, Heart and Vascular Institute, Cleveland Clinic, Cleveland, OH, 2Minneapolis Heart Institute at Abbott Northwestern Hospital, Minneapolis, MN, 3Kiniksa Pharmaceuticals, Ltd., Hamilton, Bermuda, 4VCU Pauley Heart Center, Virginia Commonwealth University, Richmond, VA, 5Department of Biomedical and Clinical Science, University of Milano, Fatebenefratelli Hospital, Milan, Italy, 6Kiniksa Pharmaceuticals Corp., Lexington, MA, 7Department of Pediatric Medicine, Division of Rheumatology, Bambino Gesù Children's Hospital, Rome, Italy, 8Cardiology Unit, The University of Vermont Medical Center, The University of Vermont, Burlington, VT, 9Cardiovascular Clinical Research Institute, Lady Davis Carmel Medical Center, Haifa, Israel, 10Division of Cardiovascular Ultrasound, Department of Cardiovascular Medicine, Mayo Clinic, Rochester, NY, 11MonashHeart, Department of Cardiology, Monash University, Clayton, Australia, 12Swedish Medical Center, Seattle, WA, 13University Cardiology, Cardiovascular and Thoracic Department, AOU Città della Salute e della Scienza di Torino, Torino, Italy

    Background/Purpose: The magnitude of pericardial delayed hyperenhancement (DHE) by cardiac magnetic resonance imaging (CMR) illustrates the severity of inflammation in pericarditis. We hypothesized that patients…
  • Abstract Number: 0452 • ACR Convergence 2021

    Total-Body 18F-FDG PET/CT Imaging: A Tool for Diagnosis and Quantifying Inflammatory Burden of Psoriatic Arthritis

    Siba Raychaudhuri1, Yasser Abdelhafez2, Smriti Kundu-Raychaudhuri2 and Abhijit Chaudhari2, 1Sacramento Veterans Affairs Medical Center (VAMC)/University of California-Davis Health, Davis, CA, 2UC Davis School of Medicine, Davis, CA

    Background/Purpose: The underlying pathology in psoriatic arthritis (PsA) is systemic inflammation. The Total Body (TB)-PET/CT with the 18F-FDG radiotracer captures glucose metabolism across the entire…
  • Abstract Number: 1402 • ACR Convergence 2021

    Clinical, Laboratory and Imaging Outcomes in Tocilizumab-Treated Patients with Large Vessel-Giant Cell Arteritis According to Early Onset Therapy

    Diana Prieto-Peña1, Isabel Martínez-Rodríguez1, Belén Atienza-Mateo2, FRANCISCO JAVIER Gómez De La Fuente1, Aida Sánchez-Salmón1, Miguel Ángel gonzalez-Gay3 and Ricardo Blanco4, 1Hospital Universitario Marqués de Valdecilla, santander, Spain, 2Group "Research in genetic epidemiology and atherosclerosis of systemic diseases and in bone metabolic diseases of the locomotor system", IDIVAL; and Department of Rheumatology, Hospital Universitario Marqués de Valdecilla, Santander, Spain, 3Research group on Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Bone Diseases of the Musculoskeletal System, IDIVAL, Division of Rheumatology, Hospital Universitario Marqués de Valdecilla; School of Medicine, Universidad de Cantabria, Santander, Spain. Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa, 4Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain

    Background/Purpose: Tocilizumab (TCZ) has shown efficacy in large vessel vasculitis (LVV)-Giant Cell Arteritis (LVV-GCA) (1-2). 18F-fluodeoxyglucose positron emission tomography (18F-FDG PET/CT) is useful to assess…
  • Abstract Number: 0163 • ACR Convergence 2021

    Diagnosis of Giant Cell Arteritis in Spain: Data from the ARTESER Registry

    Eugenio De Miguel1, Jesús T. Sánchez-Costa2, Javier Narvaez3, Miguel Ángel gonzalez-Gay4, Noemí Garrido-Puñal5, Paula V. Estrada-Alarcon6, Iñigo Hernández-Rodríguez7, Elisa Fernández-Fernández8, María T. Silva-Diaz9, Jesús A. Valero-Jaimes10, Ismael González-Fernández11, Julio Sánchez12, Judit Lluch13, Eva Galindez-Agirregoikoa14, Javier Mendizábal-Mateos15, Luis Rodriguez Rodriguez16, Javier Loricera García17, Alejandro Muñoz18, Santos Castañeda19, Patricia Moya20, Patricia Morán-Álvarez21, Vanessa A. Navarro-Angeles6, Joan Calvet-Fontova22, Ivette Casafont23, Francisco Ortiz-Sanjuán24, Selene Labrada-Arrabal25, Cristina Campos-Fernández26, María Alcalde-Villar27, Antonio Juan-Mas28 and Ricardo Blanco29, 1Hospital Universitario La Paz, Madrid, Spain, 2Spanish Society of Rheumatology, Madrid, Spain, 3Division of Rheumatology, Hospital Universitario de Bellvitge, Barcelona, Spain, 4Research group on Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Bone Diseases of the Musculoskeletal System, IDIVAL, Division of Rheumatology, Hospital Universitario Marqués de Valdecilla; School of Medicine, Universidad de Cantabria, Santander, Spain. Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa, 5Hospital Universitario Virgen del Rocío, Sevilla, Spain, 6Hospital de Sant Joan Despí Moisès Broggi. Sant Joan Despí, Barcelona, Spain, 7Complejo Hospitalario Universitario de Vigo, Vigo, Spain, 8Rheumatology department, La Paz University Hospital, Madrid, Spain, 9Complejo Hospitalario Universitario de La Coruña, Coruña, Spain, 10Hospital Universitario Donostia, Donostia-San Sebasti, Spain, 11Hospital Universitario de León, León, Spain, 12Hospital Universitario 12 de Octubre, Madrid, Spain, 13Hospital Universitari Bellvitge, Hospitalet de Llobregat, Spain, 14Hospital Universitario de Basurto, Bilbao, Spain, 15H. Navarra, Navarra, Spain, 16Hospital Clinico San Carlos, Madrid, Spain, 17Hospital Universitario Marqués de Valdecilla, Santander, Spain, 18Hospital Universitario Virgen del Rocío, Sevial, Spain, 19Hospital Universitario de la Princesa, Madrid, Spain, 20Hospital Sant Pau, Barcelona, Spain, 21Hospital Universitario Ramón y Cajal, Madrid, Spain, 22Hospital Universitari Parc Tauli, Sabadell, Spain, 23Hospital Universitari Germans Trias i Pujol, Barcelona, Badalona, Spain, 24H. La Fe, Valencia, Spain, 25Hospital del Mar, Barcelona, Spain, 26Consorci Hospital General Universitari de Valencia, Valencia, Spain, 27Hospital Universitario Severo Ochoa, Leganés, Spain, 28Hospital Universitario Son Llàtzer, Palma de Mallorca, Spain, 29Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain

    Background/Purpose: To standardize research studies different classification systems are used. Currently, the ACR Giant Cell Arteritis (GCA) 19901 classification criteria is probably the most widely…
  • Abstract Number: 0466 • ACR Convergence 2021

    Subclinical Large Vessel Vasculitis in Polymyalgia Rheumatica

    Eugenio De Miguel1, Pierluigi Macchioni2, Edoardo Conticini3, Corrado Campochiaro4, Rositsa Karalilova5, Giulia Klinowski2, Paolo Falsetti3, Irene Monjo6, Alessandro Tomelleri7, Zguro Batalov5 and Alojzija Hocevar8, 1Hospital Universitario La Paz, Madrid, Spain, 2Department of Rheumatology, IRCCS-S.Maria Nuova, Reggio Emilia, Italy, 3Rheumatology Unit, Department of Medicine, Surgery and Neurosciences, University of Siena, Siena, Italy, 4Unit of Immunology, Rheumatology, Allergy and Rare Diseases (UnIRAR). San Raffaele Scientific Institute, Milan. Italy, Milan, Italy, 5Medical University of Plovdiv, University Hospital Kaspela, Plovdiv, Bulgaria, 6Hospital La Paz - IdiPAZ, Madrid, Spain, 7Unit of Immunology, Rheumatology, Allergy and Rare Diseases (UnIRAR). San Raffaele Scientific Institute, Milan, Milan, Italy, 8UKC Ljubjana, Ljubjana, Slovenia

    Background/Purpose: Polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) are closely related diseases. PMR occurs in approximately 50 % of GCA patients1, however the frequency…
  • Abstract Number: 1403 • ACR Convergence 2021

    Giant Cell Arteritis Subtypes: Data from the ARTESER Registry

    Eugenio De Miguel1, Jesús T. Sánchez-Costa2, Javier Narvaez3, Miguel Ángel gonzalez-Gay4, Noemí Garrido-Puñal5, Paula V. Estrada-Alarcon6, Rafael B. Melero-González7, Elisa Fernández-Fernández8, María T. Silva-Diaz9, Joaquín M. Belzunegui10, Clara Moriano11, Julio Sánchez12, Judit Lluch13, Itziar Calvo14, Vicente Aldasoro15, Leticia León-Mateos16, Javier Loricera García17, Alberto Ruíz-Román5, Cristina Valero-Martínez18, Patricia Moya19, Marina Tortosa-Cabañas20, Vanessa A. Navarro-Angeles6, Carles Galisteo21, Anne Riveros-Frutos22, Jose A. Román-Ivorra23, Selene Labrada-Arrabal24, Margarida Vasques-Rocha25, Carlota L. Iñiguez-Ubiaga26, María García-González27 and Ricardo Blanco28, 1Hospital Universitario La Paz, Madrid, Spain, 2Spanish Society of Rheumatology, Madrid, Spain, 3Division of Rheumatology, Hospital Universitario de Bellvitge, Barcelona, Spain, 4Research group on Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Bone Diseases of the Musculoskeletal System, IDIVAL, Division of Rheumatology, Hospital Universitario Marqués de Valdecilla; School of Medicine, Universidad de Cantabria, Santander, Spain. Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa, 5Hospital Universitario Virgen del Rocío, Sevilla, Spain, 6Hospital de Sant Joan Despí Moisès Broggi. Sant Joan Despí, Barcelona, Spain, 7Complejo Hospitalario Universitario de Vigo, Vigo, Spain, 8Rheumatology department, La Paz University Hospital, Madrid, Spain, 9Complejo Hospitalario Universitario de La Coruña, Coruña, Spain, 10Hospital Universitario Donostia, Donostia-San Sebasti, Spain, 11Hospital Universitario de León, León, Spain, 12Hospital Universitario 12 de Octubre, Madrid, Spain, 13Hospital Universitari Bellvitge, Hospitalet de Llobregat, Spain, 14Basurto University Hospital, Bilbao, Spain, 15Complejo Hospitalario de Navarra, Pamplona, Spain, 16Hospital Clínico San Carlos. Madrid. Spain, Madrid, Spain, 17Hospital Universitario Marqués de Valdecilla, Santander, Spain, 18Hospital Universitario de La Princesa, Madrid, Spain, 19Hospital Sant Pau, Barcelona, Spain, 20Hospital Universitario Ramón y Cajal, Madrid, Spain, 21Hospital Universitari Parc Tauli, Saadell, Spain, 22Hospital Germans Trias i Pujol, Badalona, Spain, 23Hospital Universitari i Politècnic La Fe, Valencia, Spain, 24Hospital del Mar, Barcelona, Spain, 25Hospital Universitario Araba, Vitoria-Gasteiz, Spain, 26Hospital Universitario Lucus Augusti, Lugo, Spain, 27Hospital Universitario de Canarias, La Laguna, Spain, 28Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain

    Background/Purpose: Giant cell arteritis (GCA) is the most common systemic vasculitis over 50 years of age. Classically, GCA was assimilated with the involvement of the…
  • Abstract Number: 0166 • ACR Convergence 2021

    Digital Extensor Paratenonitis Is Frequent in Early Rheumatoid Arthritis

    Mihaela Maruseac1, Adrien NZEUSSEU TOUKAP2 and Maria S. Stoenoiu3, 1Rheumatology department, Cliniques Universitaires Saint-Luc, Brussel, Belgium, 2Rheumatology department, Cliniques Universitaires Saint-Luc, Institut de Recherche Expérimentale et Clinique (IREC), Université catholique de Louvain, Brussels, Belgium, 3Rheumatology department, Cliniques Universitaires Saint-Luc, Institut de Recherche Expérimentale et Clinique (IREC), Brussels, Belgium

    Background/Purpose: Finger extensor tendon involvement (FEP) or paratenonitis has previously been described by ultrasound (US) in patients suffering from early psoriatic arthritis. Contradictory results were…
  • Abstract Number: 0503 • ACR Convergence 2021

    18F-fluorodeoxyglucose Positron Emission Tomography as a Predictor of Angiographic Progression of Disease in Large-vessel Vasculitis

    Kaitlin Quinn1, Mark A. Ahlman2, Hugh Alessi3, Ashkan Malayeri2, Jamie Marko2, Elaine Novakovich2 and Peter Grayson4, 1National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH), Washington, DC, 2National Institutes of Health, Bethesda, MD, 3National Institutes of Health, Bethesda, Maryland, 4National Institutes of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH), Bethesda, MD

    Background/Purpose: There is limited prospective data characterizing arterial lesions over time in giant cell arteritis (GCA) and Takayasu’s arteritis (TAK), the two main forms of…
  • Abstract Number: 1414 • ACR Convergence 2021

    The Current State of Expedited Referral Systems Incorporating Vasculitis Ultrasound for the Diagnosis of Giant Cell Arteritis in Rheumatology Practices in the United States

    Mark Matza1, Karina Torralba2 and Minna Kohler3, 1Massachusetts General Hospital, Boston, MA, 2Division of Rheumatology, Department of Medicine, Loma Linda University Healthcare, Loma Linda, CA, 3Massachusetts General Hospital, Harvard Medical School, Boston, MA

    Background/Purpose: Expedited referral systems or “fast-track” clinics incorporating vasculitis ultrasound (VUS) into the evaluation of patients with suspected giant cell arteritis (GCA) have shown reduced…
  • « Previous Page
  • 1
  • …
  • 17
  • 18
  • 19
  • 20
  • 21
  • …
  • 36
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology